HTL is the world leader in the development and production of pharmaceutical grade biopolymers used to develop life-changing treatments for millions of patients.
A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined for over 30 years its innovative functional biopolymer platform that has enabled it to produce "customised" pharmaceutical grade products for the leaders of the pharmaceutical and medical devices sectors in therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology and urology
Thanks to its dedicated R&D team, its partnerships and its incubator, HTL is now driving innovation in the biopolymer sector. Its R&D strategy aims to address unmet medical needs by creating new types of biopolymers, modifying their physico-chemical properties, and exploring new medical applications in cutting-edge areas such as bioprinting and drug delivery.
very.

Biotechnology

Health Care

Pharmaceutical

HTL Biotechnology

François Fournier

Nathalie Chevallon

Laurent Bouillaut

Jason O'Neill

Francis B Maddalo

Marie-Armelle Floc'H

Nicolas Préfol

Laurène Brodiez

Emmanuel Lefèvre

Cyril Picault

Christophe Coyard

Bertrand Hurtault

The Leadership Team at HTL Biotechnology is responsible for setting the strategic direction and vision of the company, ensuring operational excellence, and driving innovation in the biopolymer sector. Comprising top executives from various functions, the team collaborates to align R&D efforts with market needs, optimize production processes, cultivate partnerships, and oversee compliance and quality standards, all while fostering a culture of growth and transformation to address unmet medical needs.

Leadership Team

Business Operations

Product Development and Management

Leadership Team

About

Team members

Other teams at HTL Biotechnology

Business Operations

Product Development and Management